216 related articles for article (PubMed ID: 21485507)
21. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
22. p63 and p73 transcriptionally regulate genes involved in DNA repair.
Lin YL; Sengupta S; Gurdziel K; Bell GW; Jacks T; Flores ER
PLoS Genet; 2009 Oct; 5(10):e1000680. PubMed ID: 19816568
[TBL] [Abstract][Full Text] [Related]
23. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
24. The role of p53 protein family in gastrointestinal malignancies.
Zaika AI; El-Rifai W
Cell Death Differ; 2006 Jun; 13(6):935-40. PubMed ID: 16557273
[No Abstract] [Full Text] [Related]
25. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
[TBL] [Abstract][Full Text] [Related]
26. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
27. Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.
Yao Y; Bellon M; Shelton SN; Nicot C
J Biol Chem; 2012 Jun; 287(24):20737-47. PubMed ID: 22496369
[TBL] [Abstract][Full Text] [Related]
28. The emerging p53 gene family.
Kaelin WG
J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
[TBL] [Abstract][Full Text] [Related]
29. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
30. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
Paull AC; Whikehart DR
Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
[TBL] [Abstract][Full Text] [Related]
31. Structure, function and regulation of p63 and p73.
Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.
Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K
FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168
[TBL] [Abstract][Full Text] [Related]
33. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
[TBL] [Abstract][Full Text] [Related]
34. p73: a complex gene for building a complex brain.
Meyer G
Cell Cycle; 2011 Apr; 10(8):1188-9. PubMed ID: 21441779
[No Abstract] [Full Text] [Related]
35. The p53 family member p73 in the regulation of cell stress response.
Rozenberg JM; Zvereva S; Dalina A; Blatov I; Zubarev I; Luppov D; Bessmertnyi A; Romanishin A; Alsoulaiman L; Kumeiko V; Kagansky A; Melino G; Ganini C; Barlev NA
Biol Direct; 2021 Nov; 16(1):23. PubMed ID: 34749806
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
[TBL] [Abstract][Full Text] [Related]
37. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li Y; Prives C
Oncogene; 2007 Apr; 26(15):2220-5. PubMed ID: 17401431
[TBL] [Abstract][Full Text] [Related]
38. Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.
Brandt T; Petrovich M; Joerger AC; Veprintsev DB
BMC Genomics; 2009 Dec; 10():628. PubMed ID: 20030809
[TBL] [Abstract][Full Text] [Related]
39. p63 and p73, the ancestors of p53.
Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
[TBL] [Abstract][Full Text] [Related]
40. P53 family: at the crossroads in cancer therapy.
Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]